Related Experiment Video
Updated: Jun 18, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
The effects of telomerase inhibition on prostate tumor-initiating cells
Calin O Marian1, Woodring E Wright, Jerry W Shay
1Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Abstract:
Prostate cancer is the most common malignancy in men, and patients with metastatic disease have poor outcome even with the most advanced therapeutic approaches. Most cancer therapies target the bulk tumor cells, but may leave intact a small population of tumor-initiating cells (TICs), which are believed to be responsible for the subsequent relapse and metastasis. Using specific surface markers (CD44, integrin alpha(2)beta(1) and CD133), Hoechst 33342 dye exclusion, and holoclone formation, we isolated TICs from a panel of prostate cancer cell lines (DU145, C4-2 and LNCaP). We have found that prostate TICs have significant telomerase activity which is inhibited by imetelstat sodium (GRN163L), a new telomerase antagonist that is currently in Phase I/II clinical trials for several hematological and solid tumor malignancies. Prostate TICs telomeres were of similar average length to the telomeres of the main population of cells and significant telomere shortening was detected in prostate TICs as a result of imetelstat treatment. These findings suggest that telomerase inhibition therapy may be able to efficiently target the prostate TICs in addition to the bulk tumor cells, providing new opportunities for combination therapies.
Insights
This study identified prostate tumor-initiating cells (TICs) with high telomerase activity. Telomerase inhibition using imetelstat sodium effectively targeted these TICs, suggesting a new therapeutic strategy for prostate cancer.
Area of Science:
- Oncology
- Cancer Biology
Background:
- Prostate cancer, a common male malignancy, often has poor outcomes in metastatic stages.
- Standard therapies may spare tumor-initiating cells (TICs), leading to relapse and metastasis.
Purpose of the Study:
- To isolate and characterize prostate TICs.
- To investigate the efficacy of telomerase inhibition on prostate TICs.
Main Methods:
- Isolation of prostate TICs using surface markers (CD44, integrin alpha(2)beta(1), CD133), Hoechst 33342 dye exclusion, and holoclone formation.
- Assessment of telomerase activity in isolated TICs.
- Treatment of TICs with imetelstat sodium (GRN163L) and evaluation of telomere length.
Main Results:
- Prostate TICs exhibited significant telomerase activity.
- Imetelstat sodium inhibited telomerase activity in prostate TICs.
- Telomere shortening was observed in prostate TICs following imetelstat treatment.
Conclusions:
- Telomerase inhibition therapy, using agents like imetelstat sodium, shows promise for targeting prostate TICs.
- This approach could offer new avenues for combination therapies in advanced prostate cancer.
Related Concept Videos
Replicative Cell Senescence
Telomeres and Telomerase
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

